Expert Q&A: Labs Must Take a Greater Role in Guiding Clinicians About Abnormal Data
Lee Fleisher, MD, advocates for clearer interpretation of test results by medical laboratory scientists
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Lee Fleisher, MD, advocates for clearer interpretation of test results by medical laboratory scientists
What happens when a whistleblower’s case is based on information that’s already been publicly disclosed?
CMS recently announced some important changes affecting PAMA price reporting, along with a list of 17 new PLA codes that will be recognized.
The US Food and Drug Administration recently issued a letter warning people not to use two different tests produced by Empowered Diagnostics.
The cost of recoveries hit an eight-year high in FY 2021, with the health care industry footing 90 percent of the bill.